Anti-Cancer Medicines Availability: European Study

Study objectives: to provide European health authorities with data on the availability of licensed anti-neoplastic medicines across Europe

The results of the European study have been published in the August 2016 issue of Annals of Oncology

Study objective

The goals of this study are:

  • to provide European health authorities with data on the availability of licensed anti-neoplastic medicines across Europe
  • to report on the actual availability of anti-neoplastic medicines to patients when they are prescribed and when patients can afford them
  • to provide data so that the European Union and the European Medicines Agency can decide how to best address and resolve the challenges identified

  Read the manuscript here